La Levée De Fonds de 138 Millions d’EUR d’Amolyt Pharma.

Goodwin a conseillé Sofinnova Partners, Intermediate Capital Group, Tekla et CTI Life Sciences. Jones Day a conseillé Amolyt Pharma. McDermott Will & Emery a conseillé Andera…

This content is for members only.
Login Join Now

Author: Georgio Naffaa

This content is for members only.
Login Join Now